Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Cannabis Suisse (CSUI) EBITDA (2016 - 2026)

Cannabis Suisse (CSUI) has disclosed EBITDA for 10 consecutive years, with -$73919.0 as the latest value for Q4 2025.

  • Quarterly EBITDA rose 18.99% to -$73919.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$276136.0 through Nov 2025, up 10.5% year-over-year, with the annual reading at -$283769.0 for FY2025, 12.3% down from the prior year.
  • EBITDA for Q4 2025 was -$73919.0 at Cannabis Suisse, up from -$83474.0 in the prior quarter.
  • The five-year high for EBITDA was $59173.0 in Q1 2021, with the low at -$674320.0 in Q2 2021.
  • Average EBITDA over 5 years is -$90129.8, with a median of -$61907.5 recorded in 2023.
  • Peak annual rise in EBITDA hit 196.94% in 2021, while the deepest fall reached 4662.15% in 2021.
  • Over 5 years, EBITDA stood at -$40769.0 in 2021, then skyrocketed by 30.55% to -$28314.0 in 2022, then tumbled by 75.32% to -$49641.0 in 2023, then crashed by 83.82% to -$91248.0 in 2024, then rose by 18.99% to -$73919.0 in 2025.
  • According to Business Quant data, EBITDA over the past three periods came in at -$73919.0, -$83474.0, and -$53016.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.